Dc. Wallace et al., MITOCHONDRIAL-DNA MUTATIONS IN HUMAN DEGENERATIVE DISEASES AND AGING, Biochimica et biophysica acta. Molecular basis of disease, 1271(1), 1995, pp. 141-151
A wide variety of mitochondrial DNA (mtDNA) mutations have recently be
en identified in degenerative diseases of the brain, heart, skeletal m
uscle, kidney and endocrine system. Generally, individuals inheriting
these mitochondrial diseases are relatively normal in early life, deve
lop symptoms during childhood, mid-life, or old age depending on the s
everity of the maternally-inherited mtDNA mutation; and then undergo a
progressive decline. These novel features of mtDNA disease are propos
ed to be the product of the high dependence of the target organs on mi
tochondrial bioenergetics, and the cumulative oxidative phosphorylatio
n (OXPHOS) defect caused by the inherited mtDNA mutation together with
the age-related accumulation mtDNA mutations in post-mitotic tissues.